Medicinal Genomics Leadership

1)DREAMing of a patent-free human genome for clinical sequencing. Nat Biotech. 2013 Oct;8

http://www.nature.com/nbt/journal/v31/n10/pdf/nbt.2703.pdf

2) Stem cell transcriptome profiling via massive-scale mRNA sequencing.Nat Methods. 2008 Jul;5(7):613-9. Epub 2008 May 30. PMID: 18516046

3)A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning.Genome Res. 2008 Jul;18(7):1051-63. Epub 2008 May 13.PMID: 18477713

4)Mapping and sequencing of structural variation from eight human genomes.Nature. 2008 May 1;453(7191):56-64.PMID: 18451855

5)Sequence and structural variation in a human genome.... McKernan et.al., Genome Res. Published online June 22, 2009, doi:10.1101/gr.091868.109

6)Evolution of genes and genomes on the Drosophila phylogeny.Nature. 2007 Nov 8;450(7167):203-18. PMID: 17994087

7)Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype.Nature. 2004 Oct 21;431(7011):946-57. PMID: 15496914

8)Protein interaction mapping on a functional shotgun sequence of Rickettsia sibirica.Nucleic Acids Res. 2004 Feb 10;32(3):1059-64. Print 2004.PMID: 14872061

9)Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.PMID: 12477932

10)The genome of M. acetivorans reveals extensive metabolic and physiological diversity.Genome Res. 2002 Apr;12(4):532-42.PMID: 11932238

11)Initial sequencing and analysis of the human genome.Nature. 2001 Feb 15;409(6822):860-921. Erratum in: Nature 2001 Aug 2;412(6846):565. Nature 2001 Jun 7;411(6838):720. Szustakowki, J [corrected to Szustakowski, J]. PMID: 11237011

12)A magnetic attraction to high-throughput genomics.Science. 1997 Jun 20;276(5320):1887-9. No abstract available. PMID: 9206843

Medicinal genomics is an early leader in harnessing advanced genomics and blockchain technology to drive sustainable productivity, transparency and safety solutions to solve the mounting challenges of cannabis cultivation and distribution.

Previously Brendan was co-founder and President of Courtagen Lifescience which brought innovative genetic testing to kids with neurological disorders. Courtagen also spent years sequencing genes associated with the endocannabinoid system. Brendan was also a co-founder of Agencourt Bioscience and Agencourt Personal Genomics. Until both firms were acquired, he was a board member and the Vice President of Operations. In this capacity, he oversaw the implementation and execution of the company's operational strategy.

Massachusetts-based Agencourt Biosciences Corporation was a leading provider of nucleic acid purification products and genomic services for life science research. Agencourt Personal Genomics develop an innovative next generation sequencing platform called SOLiD.

Brendan holds a BS in Management Science from Muhlenberg College and an MBA from Rensselaer's Lally School of Management and Technology. While at Rensselaer, McKernan received the Delmar W. Karger Award in Management for outstanding academic and leadership achievements. In 2006 Brendan was named the William F. Glaser '53 Rensselaer Entrepreneur of the Year.

Brendan is also a board member of the Avon Old Farms School where he serves as Co-Vice Chairman and Treasurer. Brendan is a member of Boston Harbor Angels where he serves on the Life Science Screening Committee.

1)DREAMing of a patent-free human genome for clinical sequencing. Nat Biotech. 2013 Oct;8

http://www.nature.com/nbt/journal/v31/n10/pdf/nbt.2703.pdf

2) Stem cell transcriptome profiling via massive-scale mRNA sequencing.Nat Methods. 2008 Jul;5(7):613-9. Epub 2008 May 30. PMID: 18516046

3)A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning.Genome Res. 2008 Jul;18(7):1051-63. Epub 2008 May 13.PMID: 18477713

4)Mapping and sequencing of structural variation from eight human genomes.Nature. 2008 May 1;453(7191):56-64.PMID: 18451855

5)Sequence and structural variation in a human genome.... McKernan et.al., Genome Res. Published online June 22, 2009, doi:10.1101/gr.091868.109

6)Evolution of genes and genomes on the Drosophila phylogeny.Nature. 2007 Nov 8;450(7167):203-18. PMID: 17994087

7)Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype.Nature. 2004 Oct 21;431(7011):946-57. PMID: 15496914

8)Protein interaction mapping on a functional shotgun sequence of Rickettsia sibirica.Nucleic Acids Res. 2004 Feb 10;32(3):1059-64. Print 2004.PMID: 14872061

9)Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.PMID: 12477932

10)The genome of M. acetivorans reveals extensive metabolic and physiological diversity.Genome Res. 2002 Apr;12(4):532-42.PMID: 11932238

11)Initial sequencing and analysis of the human genome.Nature. 2001 Feb 15;409(6822):860-921. Erratum in: Nature 2001 Aug 2;412(6846):565. Nature 2001 Jun 7;411(6838):720. Szustakowki, J [corrected to Szustakowski, J]. PMID: 11237011

12)A magnetic attraction to high-throughput genomics.Science. 1997 Jun 20;276(5320):1887-9. No abstract available. PMID: 9206843

1)DREAMing of a patent-free human genome for clinical sequencing. Nat Biotech. 2013 Oct;8

http://www.nature.com/nbt/journal/v31/n10/pdf/nbt.2703.pdf

2) Stem cell transcriptome profiling via massive-scale mRNA sequencing.Nat Methods. 2008 Jul;5(7):613-9. Epub 2008 May 30. PMID: 18516046

3)A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning.Genome Res. 2008 Jul;18(7):1051-63. Epub 2008 May 13.PMID: 18477713

4)Mapping and sequencing of structural variation from eight human genomes.Nature. 2008 May 1;453(7191):56-64.PMID: 18451855

5)Sequence and structural variation in a human genome.... McKernan et.al., Genome Res. Published online June 22, 2009, doi:10.1101/gr.091868.109

6)Evolution of genes and genomes on the Drosophila phylogeny.Nature. 2007 Nov 8;450(7167):203-18. PMID: 17994087

7)Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype.Nature. 2004 Oct 21;431(7011):946-57. PMID: 15496914

8)Protein interaction mapping on a functional shotgun sequence of Rickettsia sibirica.Nucleic Acids Res. 2004 Feb 10;32(3):1059-64. Print 2004.PMID: 14872061

9)Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.PMID: 12477932

10)The genome of M. acetivorans reveals extensive metabolic and physiological diversity.Genome Res. 2002 Apr;12(4):532-42.PMID: 11932238

11)Initial sequencing and analysis of the human genome.Nature. 2001 Feb 15;409(6822):860-921. Erratum in: Nature 2001 Aug 2;412(6846):565. Nature 2001 Jun 7;411(6838):720. Szustakowki, J [corrected to Szustakowski, J]. PMID: 11237011

12)A magnetic attraction to high-throughput genomics.Science. 1997 Jun 20;276(5320):1887-9. No abstract available. PMID: 9206843

Medicinal genomics is an early leader in harnessing advanced genomics and blockchain technology to drive sustainable productivity, transparency and safety solutions to solve the mounting challenges of cannabis cultivation and distribution.

Previously Brendan was co-founder and President of Courtagen Lifescience which brought innovative genetic testing to kids with neurological disorders. Courtagen also spent years sequencing genes associated with the endocannabinoid system. Brendan was also a co-founder of Agencourt Bioscience and Agencourt Personal Genomics. Until both firms were acquired, he was a board member and the Vice President of Operations. In this capacity, he oversaw the implementation and execution of the company's operational strategy.

Massachusetts-based Agencourt Biosciences Corporation was a leading provider of nucleic acid purification products and genomic services for life science research. Agencourt Personal Genomics develop an innovative next generation sequencing platform called SOLiD.

Brendan holds a BS in Management Science from Muhlenberg College and an MBA from Rensselaer's Lally School of Management and Technology. While at Rensselaer, McKernan received the Delmar W. Karger Award in Management for outstanding academic and leadership achievements. In 2006 Brendan was named the William F. Glaser '53 Rensselaer Entrepreneur of the Year.

Brendan is also a board member of the Avon Old Farms School where he serves as Co-Vice Chairman and Treasurer. Brendan is a member of Boston Harbor Angels where he serves on the Life Science Screening Committee.